• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

Research Brief on 1-(6-Chloro-2-pyridinyl)methyl-cyclobutanamine (CAS: 2358095-38-0): Recent Advances and Applications

The compound 1-(6-Chloro-2-pyridinyl)methyl-cyclobutanamine (CAS: 2358095-38-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, pharmacological activity, and emerging roles in drug discovery.

Recent studies have highlighted the compound's role as a key intermediate in the synthesis of novel bioactive molecules. A 2023 publication in the Journal of Medicinal Chemistry demonstrated its utility in constructing cyclobutane-containing scaffolds, which are increasingly recognized for their conformational rigidity and metabolic stability in drug design. The presence of both the chloropyridine and cyclobutylamine moieties offers distinct advantages for molecular interactions with biological targets.

Pharmacological investigations have revealed promising activity profiles for derivatives of 1-(6-Chloro-2-pyridinyl)methyl-cyclobutanamine. Research from the University of Cambridge (2024) identified potent inhibitory effects against specific kinase targets involved in inflammatory pathways, with IC50 values in the low micromolar range. These findings suggest potential applications in developing treatments for autoimmune disorders and certain cancers.

The compound's mechanism of action appears to involve multiple pathways. Structural analyses indicate that the chloropyridine group facilitates π-π stacking interactions with aromatic residues in enzyme active sites, while the cyclobutylamine moiety contributes to binding affinity through steric complementarity. This dual functionality makes it particularly valuable for structure-activity relationship studies in medicinal chemistry programs.

Recent advancements in synthetic methodologies have improved access to this compound and its derivatives. A 2024 Nature Protocols paper detailed an optimized three-step synthesis from commercially available starting materials, achieving an overall yield of 68% with excellent purity (>99%). This development has significantly enhanced its availability for research purposes.

Looking forward, 1-(6-Chloro-2-pyridinyl)methyl-cyclobutanamine continues to show promise as a versatile building block in pharmaceutical research. Current clinical investigations are exploring its derivatives as potential candidates for neurological disorders, leveraging its ability to cross the blood-brain barrier. The compound's unique combination of structural features and demonstrated biological activity positions it as an important focus area for future drug discovery efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)